These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 19509009)

  • 1. Low HDL cholesterol is associated with the risk of stroke in elderly diabetic individuals: changes in the risk for atherosclerotic diseases at various ages.
    Hayashi T; Kawashima S; Itoh H; Yamada N; Sone H; Watanabe H; Hattori Y; Ohrui T; Yokote K; Nomura H; Umegaki H; Iguchi A;
    Diabetes Care; 2009 Jul; 32(7):1221-3. PubMed ID: 19509009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Importance of high-density lipoprotein cholesterol levels in elderly diabetic individuals with type IIb dyslipidemia: A 2-year survey of cardiovascular events.
    Ina K; Hayashi T; Araki A; Kawashima S; Sone H; Watanabe H; Ohrui T; Yokote K; Takemoto M; Kubota K; Noda M; Noto H; Ding QF; Zhang J; Yu ZY; Yoon BK; Nomura H; Kuzuya M;
    Geriatr Gerontol Int; 2014 Oct; 14(4):806-10. PubMed ID: 24215618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic predictors of ischemic heart disease and cerebrovascular attack in elderly diabetic individuals: difference in risk by age.
    Hayashi T; Araki A; Kawashima S; Sone H; Watanabe H; Ohrui T; Yokote K; Takemoto M; Kubota K; Noda M; Noto H; Ina K; Nomura H;
    Cardiovasc Diabetol; 2013 Jan; 12():10. PubMed ID: 23302697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age, gender, insulin and blood glucose control status alter the risk of ischemic heart disease and stroke among elderly diabetic patients.
    Hayashi T; Kawashima S; Nomura H; Itoh H; Watanabe H; Ohrui T; Yokote K; Sone H; Hattori Y; Yoshizumi M; Ina K; Kubota K;
    Cardiovasc Diabetol; 2011 Oct; 10():86. PubMed ID: 21978180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid measures for prediction of incident cardiovascular disease in diabetic and non-diabetic adults: results of the 8.6 years follow-up of a population based cohort study.
    Tohidi M; Hatami M; Hadaegh F; Safarkhani M; Harati H; Azizi F
    Lipids Health Dis; 2010 Jan; 9():6. PubMed ID: 20096127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factor analyses for macrovascular complication in nonobese NIDDM patients. Multiclinical Study for Diabetic Macroangiopathy (MSDM).
    Ito H; Harano Y; Suzuki M; Hattori Y; Takeuchi M; Inada H; Inoue J; Kawamori R; Murase T; Ouchi Y; Umeda F; Nawata H; Orimo H
    Diabetes; 1996 Jul; 45 Suppl 3():S19-23. PubMed ID: 8674883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Macrovascular diseases-based on the data of Japanese cohort study (JCDM) including 1,016 very elderly diabetic individuals older than 75 years old].
    Hayashi T
    Nihon Rinsho; 2013 Nov; 71(11):1999-2004. PubMed ID: 24397173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of HMG-CoA reductase inhibitors in the prevention of cerebrovascular attack in 1016 patients older than 75 years among 4014 type 2 diabetic individuals.
    Hayashi T; Kubota K; Kawashima S; Sone H; Watanabe H; Ohrui T; Yokote K; Takemoto M; Araki A; Noda M; Noto H; Sakuma I; Yoshizumi M; Ina K; Nomura H;
    Int J Cardiol; 2014 Dec; 177(3):860-6. PubMed ID: 25466567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triglycerides and HDL cholesterol: stars or second leads in diabetes?
    Bitzur R; Cohen H; Kamari Y; Shaish A; Harats D
    Diabetes Care; 2009 Nov; 32 Suppl 2(Suppl 2):S373-7. PubMed ID: 19875584
    [No Abstract]   [Full Text] [Related]  

  • 10. Total cholesterol/HDL-cholesterol ratio discordance with LDL-cholesterol and non-HDL-cholesterol and incidence of atherosclerotic cardiovascular disease in primary prevention: The ARIC study.
    Quispe R; Elshazly MB; Zhao D; Toth PP; Puri R; Virani SS; Blumenthal RS; Martin SS; Jones SR; Michos ED
    Eur J Prev Cardiol; 2020 Oct; 27(15):1597-1605. PubMed ID: 31291776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum lipid profiles and their relationship to cardiovascular disease in the elderly: the PREV-ICTUS study.
    Lozano JV; Pallarés V; Cea-Calvo L; Llisterri JL; Fernández-Pérez C; Martí-Canales JC; Aznar J; Gil-Guillén V; Redón J;
    Curr Med Res Opin; 2008 Mar; 24(3):659-70. PubMed ID: 18218194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood lipids and lipoproteins in relation to incidence and mortality risks for CVD and cancer in the prospective EPIC-Heidelberg cohort.
    Katzke VA; Sookthai D; Johnson T; Kühn T; Kaaks R
    BMC Med; 2017 Dec; 15(1):218. PubMed ID: 29254484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of cardiovascular disease risk associated with 3 lipid measures in Japanese adults.
    Takeuchi T; Nemoto K; Takahashi O; Urayama KY; Deshpande GA; Izumo H
    J Clin Lipidol; 2014; 8(5):501-9. PubMed ID: 25234563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipids, Apolipoproteins, and Risk of Atherosclerotic Cardiovascular Disease in Persons With CKD.
    Bajaj A; Xie D; Cedillo-Couvert E; Charleston J; Chen J; Deo R; Feldman HI; Go AS; He J; Horwitz E; Kallem R; Rahman M; Weir MR; Anderson AH; Rader DJ;
    Am J Kidney Dis; 2019 Jun; 73(6):827-836. PubMed ID: 30686529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-HDL cholesterol and apolipoprotein B predict cardiovascular disease events among men with type 2 diabetes.
    Jiang R; Schulze MB; Li T; Rifai N; Stampfer MJ; Rimm EB; Hu FB
    Diabetes Care; 2004 Aug; 27(8):1991-7. PubMed ID: 15277429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is atherosclerosis in diabetes and impaired fasting glucose driven by elevated LDL cholesterol or by decreased HDL cholesterol?
    Drexel H; Aczel S; Marte T; Benzer W; Langer P; Moll W; Saely CH
    Diabetes Care; 2005 Jan; 28(1):101-7. PubMed ID: 15616241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Conventional Lipoprotein Tests and Apolipoproteins in the Prediction of Cardiovascular Disease.
    Welsh C; Celis-Morales CA; Brown R; Mackay DF; Lewsey J; Mark PB; Gray SR; Ferguson LD; Anderson JJ; Lyall DM; Cleland JG; Jhund PS; Gill JMR; Pell JP; Sattar N; Welsh P
    Circulation; 2019 Aug; 140(7):542-552. PubMed ID: 31216866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low levels of high-density lipoprotein cholesterol in patients with atherosclerotic stroke: a prospective cohort study.
    Yeh PS; Yang CM; Lin SH; Wang WM; Chen PS; Chao TH; Lin HJ; Lin KC; Chang CY; Cheng TJ; Li YH
    Atherosclerosis; 2013 Jun; 228(2):472-7. PubMed ID: 23618097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid levels and the risk of ischemic stroke in women.
    Kurth T; Everett BM; Buring JE; Kase CS; Ridker PM; Gaziano JM
    Neurology; 2007 Feb; 68(8):556-62. PubMed ID: 17310025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A cross sectional study comparing traditional risk factors with N-terminal pro-BNP in high risk groups for cardiovascular disease in Trinidad, West Indies.
    Shivananda Nayak B; Teelucksingh S; Jagessar A; Maharaj S; Maharaj N
    Diabetes Metab Syndr; 2013; 7(1):8-11. PubMed ID: 23517788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.